Molecule Details
| InChIKey | YPOHNWIPWIEUFZ-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-cyclohexyl-2-N-[3-(2-oxopyrrolidin-1-yl)propyl]piperazine-1,2-dicarboxamide |
| Canonical SMILES | O=C(NCCCN1CCCC1=O)C1CN(C2c3ccc(Cl)cc3CCc3cc(Br)cnc32)CCN1C(=O)NC1CCCCC1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.81 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile